Repurposing of metformin and colchicine reveals differential modulation of acute and chronic kidney injury
Abstract Acute kidney injury (AKI) is a major health problem affecting millions of patients globally. There is no effective treatment for AKI and new therapies are urgently needed. Novel drug development, testing and progression to clinical trials is overwhelmingly expensive. Drug repurposing is a m...
Guardado en:
Autores principales: | Maryam El-Rashid, Danny Nguyen-Ngo, Nikita Minhas, Daniel N. Meijles, Jennifer Li, Kedar Ghimire, Sohel Julovi, Natasha M. Rogers |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ef53a9104a44465b8875a257fc27d12a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The impact of metformin in chronic kidney disease-mineral and bone disorder
por: Rohollah Masumi, et al.
Publicado: (2021) -
Metformin prevents stroke damage in non-diabetic female mice with chronic kidney disease
por: Maria Grissi, et al.
Publicado: (2021) -
Colchicine, fragmented QRS, coronavirus disease 2019, and more
por: Çetin Erol
Publicado: (2021) -
Colchicine inhibits ROS generation in response to glycoprotein VI stimulation
por: G. J. Pennings, et al.
Publicado: (2021) -
Impact of colchicine on mortality in patients with COVID-19: A meta-analysis
por: Dimitrios A. Vrachatis, et al.
Publicado: (2021)